These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
23. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Jantunen E; Wiklund T; Juvonen E; Putkonen M; Lehtinen T; Kuittinen O; Franssila K; Söderström KO; Leppä S; Elonen E; Remes K; Nousiainen T Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776 [TBL] [Abstract][Full Text] [Related]
25. Hematopoietic stem cell transplantation in peripheral T-cell lymphomas. Paolo C; Lucia F; Anna D Leuk Lymphoma; 2007 Aug; 48(8):1496-501. PubMed ID: 17701579 [TBL] [Abstract][Full Text] [Related]
26. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation. Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529 [TBL] [Abstract][Full Text] [Related]
27. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma]. Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818 [TBL] [Abstract][Full Text] [Related]
28. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529 [TBL] [Abstract][Full Text] [Related]
29. Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group. Rodríguez J; Conde E; Gutiérrez A; Arranz R; León A; Marín J; Bendandi M; Albo C; Caballero MD; Eur J Haematol; 2007 Jul; 79(1):32-8. PubMed ID: 17598836 [TBL] [Abstract][Full Text] [Related]
30. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A; Forman SJ Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658 [TBL] [Abstract][Full Text] [Related]
31. Current state of art for transplantation paradigms in peripheral T-cell lymphomas. Perrone G; Farina L; Corradini P Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932 [TBL] [Abstract][Full Text] [Related]
32. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208 [TBL] [Abstract][Full Text] [Related]
33. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report]. Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855 [TBL] [Abstract][Full Text] [Related]
35. The role of high dose chemotherapy and autologous stem-cell transplantation in peripheral T-cell lymphoma: a review of the literature and new perspectives. Yared J; Kimball A Cancer Treat Rev; 2013 Feb; 39(1):51-9. PubMed ID: 22541889 [TBL] [Abstract][Full Text] [Related]
36. Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis. Yin J; Wei J; Xu JH; Xiao Y; Zhang YC Acta Haematol; 2014; 131(2):114-25. PubMed ID: 24158006 [TBL] [Abstract][Full Text] [Related]
37. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Rodriguez-Abreu D; Filho VB; Zucca E Hematol Oncol; 2008 Mar; 26(1):8-20. PubMed ID: 18050364 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431 [TBL] [Abstract][Full Text] [Related]
39. Autologous and allogeneic stem cell transplantation in Hodgkin's lymphoma. Sureda A Hematol Oncol Clin North Am; 2007 Oct; 21(5):943-60. PubMed ID: 17908630 [TBL] [Abstract][Full Text] [Related]
40. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire. Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M; J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]